✦ LIBER ✦

Influence of CYP2C19 genotype on the pharmacokinetics of R483, a CYP2C19 substrate, in healthy subjects and type 2 diabetes patients

✍ Scribed by Katrijn Bogman; Mariabeth Silkey; Siew Pheng Chan; Brian Tomlinson; Cornelia Weber

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of allicin on CYP2C19 and CYP3A4

✍ Li-Jun Yang; Lan Fan; Zhao-Qian Liu; Yan-Mei Mao; Dong Guo; Li-Hui Liu; Zhi-Rong 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 189 KB

The CYP2C19 ultra-rapid metabolizer geno

✍ Guo Wang; He-Ping Lei; Zhi Li; Zhi-Rong Tan; Dong Guo; Lan Fan; Yao Chen; Dong-L 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 127 KB

The contribution of the enzymes CYP2D6 a

✍ M. A. Van Agtmael; C. A. A. Van Der Graaf; T. K. Dien; R. P. Koopmans; C. J. Van 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 806 KB

Pharmacokinetics of three proton pump in

✍ Hai-Ling Qiao; Yu-Rong Hu; Xin Tian; Lin-Jing Jia; Na Gao; Li-Rong Zhang; Yu-Zho 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 127 KB

Effects of the CYP3A5 genotype on omepra

✍ Katsuyoshi Sugimoto; Tsukasa Uno; Tomonori Tateishi 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 116 KB

Effect of CYP2C19 genotypes on the pharm

✍ Yu-Cheng Sheng; Kun Wang; Ying-Chun He; Juan Yang; Qing-Shan Zheng 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 121 KB